AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 259 filers reported holding AMICUS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $92,000 | -77.1% | 8,856 | -76.3% | 0.01% | -73.7% |
| Q2 2022 | $402,000 | +13.6% | 37,407 | 0.0% | 0.02% | +35.7% |
| Q1 2022 | $354,000 | -24.7% | 37,407 | -8.1% | 0.01% | -17.6% |
| Q4 2021 | $470,000 | -13.6% | 40,716 | -28.5% | 0.02% | 0.0% |
| Q3 2021 | $544,000 | -13.2% | 56,950 | -12.4% | 0.02% | +13.3% |
| Q2 2021 | $627,000 | -2.3% | 65,000 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $642,000 | -0.8% | 65,000 | +131.9% | 0.02% | +7.1% |
| Q4 2020 | $647,000 | +52.2% | 28,028 | -6.9% | 0.01% | +55.6% |
| Q3 2020 | $425,000 | -12.4% | 30,120 | -6.3% | 0.01% | -18.2% |
| Q2 2020 | $485,000 | +50.2% | 32,138 | -8.2% | 0.01% | +37.5% |
| Q1 2020 | $323,000 | -5.3% | 35,008 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $341,000 | +21.4% | 35,008 | 0.0% | 0.01% | +33.3% |
| Q3 2019 | $281,000 | – | 35,008 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Morgenthaler Management Partners IX, LLC | 1,783,948 | $17,304,000 | 18.83% |
| FRAZIER MANAGEMENT LLC | 2,918,291 | $28,307,000 | 11.84% |
| Avoro Capital Advisors LLC | 3,515,611 | $34,101,000 | 11.75% |
| Perceptive Advisors | 15,239,444 | $147,823,000 | 10.94% |
| Redmile Group, LLC | 10,280,620 | $99,722,000 | 7.46% |
| ACUTA CAPITAL PARTNERS, LLC | 1,502,661 | $14,576,000 | 6.97% |
| SECTORAL ASSET MANAGEMENT INC | 7,973,436 | $77,342,000 | 3.30% |
| Asymmetry Capital Management, L.P. | 195,206 | $1,893,000 | 2.86% |
| Convector Capital Management, LP | 210,500 | $2,042,000 | 1.92% |
| Palo Alto Investors LP | 3,551,173 | $34,446,000 | 1.92% |